Tianhong Li, Ph.D. - Publications

Affiliations: 
2003 Northwestern University, Evanston, IL 

55 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Li H, Xu Y, Wan B, Song Y, Zhan P, Hu Y, Zhang Q, Zhang F, Liu H, Li T, Sugimura H, Cappuzzo F, Lin D, Lv T. The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients. Translational Lung Cancer Research. 8: 429-449. PMID 31555517 DOI: 10.21037/tlcr.2019.08.04  0.44
2019 Gregg JP, Li T, Yoneda KY. Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey. Translational Lung Cancer Research. 8: 286-301. PMID 31367542 DOI: 10.21037/tlcr.2019.04.14  0.36
2019 Xiao W, Ma W, Wei S, Li Q, Liu R, Carney RP, Yang K, Lee J, Nyugen A, Yoneda KY, Lam KS, Li T. Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer. Journal of Hematology & Oncology. 12: 83. PMID 31349855 DOI: 10.1186/s13045-019-0764-z  0.84
2019 Xiao W, Ma W, Wei S, Li Q, Liu R, Carney RP, Yang K, Lee J, Nyugen A, Yoneda KY, Lam KS, Li T. High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer. Journal of Hematology & Oncology. 12: 56. PMID 31182116 DOI: 10.1186/s13045-019-0740-7  0.84
2019 Liang X, Junaid M, Wang Z, Li T, Xu N. Spatiotemporal distribution, source apportionment and ecological risk assessment of PBDEs and PAHs in the Guanlan River from rapidly urbanizing areas of Shenzhen, China. Environmental Pollution (Barking, Essex : 1987). 250: 695-707. PMID 31035152 DOI: 10.1016/j.envpol.2019.04.107  0.72
2019 Gong J, Gregg JP, Ma W, Yoneda K, Moore EH, Daly ME, Zhang Y, Williams MJ, Li T. Squamous Cell Transformation of Primary Lung Adenocarcinoma in a Patient With EML4-ALK Fusion Variant 5 Refractory to ALK Inhibitors. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 297-301. PMID 30959466 DOI: 10.6004/jnccn.2019.7291  0.84
2019 Shi Y, Zhang J, Tian X, Wu X, Li T, Lu C, Shen Y. Isolation of 11,12- seco-Rifamycin W Derivatives Reveals a Cleavage Pattern of the Rifamycin Ansa Chain. Organic Letters. PMID 30714736 DOI: 10.1021/acs.orglett.8b03792  0.52
2018 Li T, Ma W, Tian EC. Ensartinib (X-396): what does it add for patients with ALK-rearranged NSCLC. Chinese Clinical Oncology. PMID 30525756 DOI: 10.21037/cco.2018.10.12  0.84
2018 Li Q, Ma W, Li T. Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer. Journal of Thoracic Disease. 10: S3186-S3191. PMID 30430029 DOI: 10.21037/jtd.2018.08.25  0.84
2018 Li T, Zhang D, Oo TN, San MM, Mon AM, Hein PP, Wang Y, Lu C, Yang X. Investigation on the Antibacterial and Anti-T3SS Activity of Traditional Myanmar Medicinal Plants. Evidence-Based Complementary and Alternative Medicine : Ecam. 2018: 2812908. PMID 30402120 DOI: 10.1155/2018/2812908  0.52
2018 Zhou C, Yuan Z, Ma W, Qi L, Mahavongtrakul A, Li Y, Li H, Gong J, Fan RR, Li J, Molmen M, Clark TA, Pavlick D, Frampton GM, Forcier B, ... ... Li T, et al. Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors. Journal of Hematology & Oncology. 11: 129. PMID 30400986 DOI: 10.1186/s13045-018-0671-8  0.84
2018 Schrock AB, Welsh A, Chung JH, Pavlick D, Bernicker EH, Creelan BC, Forcier B, Ross JS, Stephens PJ, Ali SM, Dagogo-Jack I, Shaw AT, Li T, Ou SI, Miller VA. Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30368012 DOI: 10.1016/j.jtho.2018.10.008  0.4
2018 Guo X, Wang Y, Zhai Z, Huang T, Zhao D, Peng X, Feng C, Xiao Y, Li T. Transcriptomic analysis of light-dependent anthocyanin accumulation in bicolored cherry fruits. Plant Physiology and Biochemistry : Ppb. PMID 30131207 DOI: 10.1016/j.plaphy.2018.08.016  0.52
2018 Yang J, Siri JG, Remais JV, Cheng Q, Zhang H, Chan KKY, Sun Z, Zhao Y, Cong N, Li X, Zhang W, Bai Y, Bi J, Cai W, Chan EYY, ... ... Li T, et al. The Tsinghua-Lancet Commission on Healthy Cities in China: unlocking the power of cities for a healthy China. Lancet (London, England). PMID 29678340 DOI: 10.1016/S0140-6736(18)30486-0  0.72
2018 Sun X, Qi H, Zhang X, Li L, Zhang J, Zeng Q, Laszlo GS, Wei B, Li T, Jiang J, Mogilner A, Fu X, Zhao M. Src activation decouples cell division orientation from cell geometry in mammalian cells. Biomaterials. 170: 82-94. PMID 29653289 DOI: 10.1016/j.biomaterials.2018.03.052  0.52
2018 Liu W, Wu T, Li Q, Zhang X, Xu X, Li T, Han Z, Wang Y. An ethylene response factor (MxERF4) functions as a repressor of Fe acquisition in Malus xiaojinensis. Scientific Reports. 8: 1068. PMID 29348657 DOI: 10.1038/s41598-018-19518-4  0.52
2017 Dyer BA, Nguyen KNB, Shukla RP, Li T, Daly ME. Durable Local Control Following Concurrent Hypofractionated Chemoradiation for a Massive Inflammatory Breast Cancer Chest Wall Recurrence. Cureus. 9: e1379. PMID 28775919 DOI: 10.7759/cureus.1379  0.36
2017 Guo X, Ma Z, Zhang Z, Cheng L, Zhang X, Li T. Small RNA-Sequencing Links Physiological Changes and RdDM Process to Vegetative-to-Floral Transition in Apple. Frontiers in Plant Science. 8: 873. PMID 28611800 DOI: 10.3389/fpls.2017.00873  0.52
2017 Zhang Z, Guo X, Ge C, Ma Z, Jiang M, Li T, Koiwa H, Yang SW, Zhang X. KETCH1 imports HYL1 to nucleus for miRNA biogenesis in Arabidopsis. Proceedings of the National Academy of Sciences of the United States of America. PMID 28348234 DOI: 10.1073/pnas.1619755114  0.52
2017 Li H, Ma W, Yoneda KY, Moore EH, Zhang Y, Pu LL, Frampton GM, Molmen M, Stephens PJ, Li T. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report. Journal of Hematology & Oncology. 10: 64. PMID 28245875 DOI: 10.1186/s13045-017-0433-z  0.84
2017 Shen X, Guo X, Guo X, Zhao D, Zhao W, Chen J, Li T. PacMYBA, a sweet cherry R2R3-MYB transcription factor, is a positive regulator of salt stress tolerance and pathogen resistance. Plant Physiology and Biochemistry : Ppb. 112: 302-311. PMID 28126679 DOI: 10.1016/j.plaphy.2017.01.015  0.52
2016 Liao X, Guo X, Wang Q, Wang Y, Zhao D, Yao L, Wang S, Liu G, Li T. Overexpression of MsDREB6.2 results in cytokinin-deficient developmental phenotypes and enhances drought tolerance in transgenic apple plants. The Plant Journal : For Cell and Molecular Biology. PMID 27754576 DOI: 10.1111/tpj.13401  0.52
2016 Pan A, Zhang H, Li Y, Lin TY, Wang F, Lee J, Cheng M, Dall'Era M, Li T, deVere White R, Pan CX, Lam KS. Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer. Nanotechnology. 27: 425103. PMID 27640312 DOI: 10.1088/0957-4484/27/42/425103  0.4
2016 Li T, Bai F, Han P, Zhang Y. Non-Point Source Pollutant Load Variation in Rapid Urbanization Areas by Remote Sensing, Gis and the L-THIA Model: A Case in Bao'an District, Shenzhen, China. Environmental Management. PMID 27617329 DOI: 10.1007/s00267-016-0743-x  0.44
2016 Lin TY, Li Y, Liu Q, Chen JL, Zhang H, Lac D, Zhang H, Ferrara KW, Wachsmann-Hogiu S, Li T, Airhart S, deVere White R, Lam KS, Pan CX. Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer. Biomaterials. 104: 339-351. PMID 27479049 DOI: 10.1016/j.biomaterials.2016.07.026  0.4
2016 Yue Y, Ni J, Ciais P, Piao S, Wang T, Huang M, Borthwick AG, Li T, Wang Y, Chappell A, Van Oost K. Lateral transport of soil carbon and land-atmosphere CO2 flux induced by water erosion in China. Proceedings of the National Academy of Sciences of the United States of America. PMID 27247397 DOI: 10.1073/pnas.1523358113  0.44
2016 Ma W, Gilligan BM, Yuan J, Li T. Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy. Journal of Hematology & Oncology. 9: 47. PMID 27234522 DOI: 10.1186/s13045-016-0277-y  0.84
2015 Wang WP, Ho PY, Chen QX, Addepalli B, Limbach PA, Li MM, Wu WJ, Jilek JL, Qiu JX, Zhang HJ, Li T, Wun T, White RD, Lam KS, Yu AM. Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization. The Journal of Pharmacology and Experimental Therapeutics. 354: 131-41. PMID 26022002 DOI: 10.1124/jpet.115.225631  0.4
2015 Gandara DR, Mack PC, Bult C, Li T, Lara PN, Riess JW, Astrow SH, Gandour-Edwards R, Cooke DT, Yoneda KY, Moore EH, Pan CX, Burich RA, David EA, Keck JG, et al. Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform. Clinical Lung Cancer. 16: 165-72. PMID 25838158 DOI: 10.1016/j.cllc.2015.03.001  0.4
2015 Zhou Y, Honda M, Zhu H, Zhang Z, Guo X, Li T, Li Z, Peng X, Nakajima K, Duan L, Zhang X. Spatiotemporal sequestration of miR165/166 by Arabidopsis Argonaute10 promotes shoot apical meristem maintenance. Cell Reports. 10: 1819-27. PMID 25801022 DOI: 10.1016/j.celrep.2015.02.047  0.52
2015 Tomlinson BK, Thomson JA, Bomalaski JS, Diaz M, Akande T, Mahaffey N, Li T, Dutia MP, Kelly K, Gong IY, Semrad T, Gandara DR, Pan CX, Lara PN. Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2480-6. PMID 25739672 DOI: 10.1158/1078-0432.CCR-14-2610  0.4
2014 Shen X, Zhao K, Liu L, Zhang K, Yuan H, Liao X, Wang Q, Guo X, Li F, Li T. A role for PacMYBA in ABA-regulated anthocyanin biosynthesis in red-colored sweet cherry cv. Hong Deng (Prunus avium L.). Plant & Cell Physiology. 55: 862-80. PMID 24443499 DOI: 10.1093/pcp/pcu013  0.52
2014 Li T, Maus MK, Desai SJ, Beckett LA, Stephens C, Huang E, Hsiang J, Zeger G, Danenberg KD, Astrow SH, Gandara DR. Large-scale screening and molecular characterization of EML4-ALK fusion variants in archival non-small-cell lung cancer tumor specimens using quantitative reverse transcription polymerase chain reaction assays. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 18-25. PMID 24346090 DOI: 10.1097/JTO.0000000000000030  0.4
2014 Gandara DR, Li T, Lara PN, Kelly K, Riess JW, Redman MW, Mack PC. Acquired resistance to targeted therapies against oncogene-driven non-small-cell lung cancer: approach to subtyping progressive disease and clinical implications. Clinical Lung Cancer. 15: 1-6. PMID 24176733 DOI: 10.1016/j.cllc.2013.10.001  0.4
2013 Hong SY, Shih YP, Li T, Carraway KL, Lo SH. CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation. Cancer Research. 73: 5266-76. PMID 23774213 DOI: 10.1158/0008-5472.CAN-12-4441  0.4
2013 Zhao K, Shen X, Yuan H, Liu Y, Liao X, Wang Q, Liu L, Li F, Li T. Isolation and characterization of dehydration-responsive element-binding factor 2C (MsDREB2C) from Malus sieversii Roem. Plant & Cell Physiology. 54: 1415-30. PMID 23757363 DOI: 10.1093/pcp/pct087  0.48
2013 Yuan H, Zhao K, Lei H, Shen X, Liu Y, Liao X, Li T. Genome-wide analysis of the GH3 family in apple (Malus × domestica). Bmc Genomics. 14: 297. PMID 23638690 DOI: 10.1186/1471-2164-14-297  0.48
2013 Maus MK, Mack PC, Astrow SH, Stephens CL, Zeger GD, Grimminger PP, Hsiang JH, Huang E, Li T, Lara PN, Danenberg KD, Gandara DR. Histology-related associations of ERCC1, RRM1, and TS biomarkers in patients with non-small-cell lung cancer: implications for therapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 582-6. PMID 23470290 DOI: 10.1097/JTO.0b013e318287c3c5  0.4
2012 Gandara DR, Li T, Lara PN, Mack PC, Kelly K, Miyamoto S, Goodwin N, Beckett L, Redman MW. Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneity. Clinical Lung Cancer. 13: 321-5. PMID 22677432 DOI: 10.1016/j.cllc.2012.05.004  0.4
2012 Li T, Guo M, Gradishar WJ, Sparano JA, Perez EA, Wang M, Sledge GW. A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103). Breast Cancer Research and Treatment. 134: 345-52. PMID 22547107 DOI: 10.1007/s10549-012-2071-z  0.32
2012 Li T, Christensen SD, Frankel PH, Margolin KA, Agarwala SS, Luu T, Mack PC, Lara PN, Gandara DR. A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial. Investigational New Drugs. 30: 741-8. PMID 20967484 DOI: 10.1007/s10637-010-9562-8  0.4
2011 Liu Y, Liu X, Zhong F, Tian R, Zhang K, Zhang X, Li T. Comparative study of phenolic compounds and antioxidant activity in different species of cherries. Journal of Food Science. 76: C633-8. PMID 22417346 DOI: 10.1111/j.1750-3841.2011.02150.x  0.52
2011 Sangha R, Davies AM, Lara PN, Mack PC, Beckett LA, Hesketh PJ, Lau D, Li T, Perkins N, Gandara DR. Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 2112-9. PMID 21892109 DOI: 10.1097/JTO.0b013e31822ae061  0.4
2010 Li T. Patient selection in non-small cell lung cancer: Histologic versus molecular subtypes? Journal of Thoracic Disease. 2: 189-91. PMID 22263043 DOI: 10.3978/j.issn.2072-1439.2010.11.9  0.4
2010 Chen H, Zhou S, Li T. Impact of extracellular polymeric substances on the settlement ability of aerobic granular sludge. Environmental Technology. 31: 1601-12. PMID 21275256 DOI: 10.1080/09593330.2010.482146  0.32
2010 Zhao H, Zhao B, Yang W, Li T. Effects of Ca2+ and Mg2+ on defluoridation in the electrocoagulation process. Environmental Science & Technology. 44: 9112-6. PMID 20977240 DOI: 10.1021/es102540t  0.36
2010 Gandara DR, Grimminger P, Mack PC, Lara PN, Li T, Danenberg PV, Danenberg KD. Association of epidermal growth factor receptor activating mutations with low ERCC1 gene expression in non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 1933-8. PMID 20975603 DOI: 10.1097/JTO.0b013e3181fd418d  0.4
2009 Pohl NM, Tong C, Fang W, Bi X, Li T, Yang W. Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts. Plos One. 4: e7774. PMID 19924303 DOI: 10.1371/journal.pone.0007774  0.4
2009 Sparano JA, Moulder S, Kazi A, Coppola D, Negassa A, Vahdat L, Li T, Pellegrino C, Fineberg S, Munster P, Malafa M, Lee D, Hoschander S, Hopkins U, Hershman D, et al. Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2942-8. PMID 19351752 DOI: 10.1158/1078-0432.CCR-08-2658  0.32
2008 Li T, Sparano JA. Farnesyl transferase inhibitors. Cancer Investigation. 26: 653-61. PMID 18665473 DOI: 10.1080/07357900801971016  0.32
2008 Li T, Yang W, Li M, Byun DS, Tong C, Nasser S, Zhuang M, Arango D, Mariadason JM, Augenlicht LH. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Molecular Nutrition & Food Research. 52: 1289-99. PMID 18435490 DOI: 10.1002/mnfr.200700331  0.4
2006 Sparano JA, Moulder S, Kazi A, Vahdat L, Li T, Pellegrino C, Munster P, Malafa M, Lee D, Hoschander S, Hopkins U, Hershman D, Wright JJ, Sebti SM. Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3013-8. PMID 16769985 DOI: 10.1200/JCO.2005.04.9114  0.32
2006 Li T, Sotgia F, Vuolo MA, Li M, Yang WC, Pestell RG, Sparano JA, Lisanti MP. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. The American Journal of Pathology. 168: 1998-2013. PMID 16723714  0.32
2004 Sparano JA, Lee S, Chen MG, Nazeer T, Einzig A, Ambinder RF, Henry DH, Manalo J, Li T, Von Roenn JH. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1491-500. PMID 15084622 DOI: 10.1200/JCO.2004.08.195  0.4
2003 Li T, Sparano JA. Inhibiting Ras signaling in the therapy of breast cancer. Clinical Breast Cancer. 3: 405-16; discussion 4. PMID 12636885 DOI: 10.3816/CBC.2003.n.005  0.32
Show low-probability matches.